Revoking the Privilege: Targeting HER2 in the Central Nervous System

Related Article

This perspective relates to "Cellular and in Vivo Activity of JNJ-28871063, A Nonquinazoline Pan-ErbB Kinase Inhibitor That Crosses the Blood-Brain Barrier and Displays Efficacy against Intracranial Tumors" by Emanuel, et al.

    This Article

    1. Published online before print November 2, 2007, doi: 10.1124/mol.107.042986 Molecular Pharmacology February 2008 vol. 73 no. 2 271-273
    1. AbstractFree
    2. Full Text
    3. Full Text (PDF)
    4. » Related Article

    Current Issue

    1. November 2009, 76 (5)
    1. Current Issue
    1. Alert me to new issues of Molecular Pharmacology